s. doğuizi Et Al. , "Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results," retina vitreus , vol.24, no.2, 2016
doğuizi, s. Et Al. 2016. Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results. retina vitreus , vol.24, no.2 .
doğuizi, s., ÖZDEK, Ş., YÜKSEL, S., GÜRELİK, İ. G., & HASANREİSOĞLU, B., (2016). Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results. retina vitreus , vol.24, no.2.
doğuizi, sibel Et Al. "Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results," retina vitreus , vol.24, no.2, 2016
doğuizi, sibel Et Al. "Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results." retina vitreus , vol.24, no.2, 2016
doğuizi, s. Et Al. (2016) . "Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results." retina vitreus , vol.24, no.2.
@article{article, author={sibel doğuizi Et Al. }, title={Intravitreal Ranibizumab and Bevacizumab Treatment for Pigment Epithelium Detachment with Exudative Age Related Macular Degeneration: Long-Term Visual and Anatomical Results}, journal={retina vitreus}, year=2016}